| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/14/2010 | CN101249064B Preparation of sulphonation aluminum phthalocyanine medicament chip taking polypyrole as medicament carrier |
| 04/14/2010 | CN101152176B Metronidazole effervescence patch and technique of preparing the same |
| 04/14/2010 | CN101130107B Method for preparing chitosan polyvinyl alcohol gel rubber containing nano granule of hydroxyapatite |
| 04/14/2010 | CN101129506B Capsule pill drops for treating electro-optical eye and anti-inflammation detoxication |
| 04/14/2010 | CN101129459B Burn and scald treating medicine and its preparation |
| 04/14/2010 | CN101129336B Method of preparing lipid nano granule |
| 04/14/2010 | CN101091799B Medicine in use for treating gastric cancer, and preparation method |
| 04/14/2010 | CN101077349B Total alkaloids of subprostrate sophora root soft capsules and preparation method and application thereof |
| 04/14/2010 | CN101049286B Gel preparation of Ciclopirox Olamine |
| 04/14/2010 | CN101023978B Zhiloukang medicine for treating hemorrhoids and fistula |
| 04/13/2010 | US7696359 Compound modified with glycerol derivative |
| 04/13/2010 | US7696338 Immunotoxin fusion proteins and means for expression thereof |
| 04/13/2010 | US7696336 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| 04/13/2010 | US7696326 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 04/13/2010 | US7696313 Prodrug compounds with isoleucine |
| 04/13/2010 | US7696219 administering composition comprising vitamin C, vitamin E, the B-complex vitamins, chromium, selenium, and zinc; can be used by patients afflicted with renal disease, renal insufficiency, or end-stage renal disease |
| 04/13/2010 | US7696178 additive-free, isotonic inhalant of pH 4.0 to 5.5; improved shelf-life at room temperature; acute and chronic endobronchial infections; cystic fibrosis |
| 04/13/2010 | US7696162 Contains a surfactant and a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.2% by weight of zinc based on the insulin content of the formulation; Polypeptide mixture; treating diabetes |
| 04/13/2010 | US7696159 Treatment for basal cell carcinoma |
| 04/13/2010 | US7696153 G-CSF conjugates |
| 04/13/2010 | US7696149 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases |
| 04/13/2010 | US7695741 Cavalia gladiata, Biota orientalis and Coptis chinensis very effective in prevention and treatment of acnes and have very little or no irritation; microbiocides; sebum ihibitors; keratolysis; antiinflammatory agents; enzyme inhibitors of 5-alpha-reductase; Chinese herbal medicine |
| 04/13/2010 | US7695738 Carbohydrate encapsulated nanoparticles |
| 04/13/2010 | US7695736 Powder of 30-90% a water-soluble cycloxygenase inhibitor, 5-60% of a buffer and 0-10% of other excipients |
| 04/13/2010 | US7695735 effervescent free; disintegration agent such as croscarmellose, crospovidone; compressible polyol such as mannitol, xylitol; lubricant such as magnesium stearate, sodium stearyl fumarate, stearic acid, micronized polyoxyethylene glycol; sweeteners, flavorings, colors; bioavailability |
| 04/13/2010 | US7695732 Nutritional composition for the treatment of pressure ulcers |
| 04/13/2010 | US7695731 Drug delivery; vascular disease; stents, grafts, anastomotic devices, perivascular wraps, sutures and staples |
| 04/13/2010 | US7695730 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 04/13/2010 | US7695729 Nonoral preparation having three-layer structure |
| 04/13/2010 | CA2564120C Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes |
| 04/13/2010 | CA2532693C Stable compositions for measuring human natriuretic peptides |
| 04/13/2010 | CA2486001C Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 04/13/2010 | CA2449747C Use of fkbp chaperones as expression tool |
| 04/13/2010 | CA2435301C Multi-arm block copolymers as drug delivery vehicles |
| 04/13/2010 | CA2415076C Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| 04/13/2010 | CA2407683C Topical anesthetic/opioid formulations and uses thereof |
| 04/13/2010 | CA2386863C Antigenic modification of polypeptides |
| 04/13/2010 | CA2381741C Directly compressible raw material for compressed products |
| 04/13/2010 | CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease |
| 04/13/2010 | CA2379626C Antibacterial composition |
| 04/13/2010 | CA2363639C Covalently bridged insulin dimers |
| 04/13/2010 | CA2331527C Biologically active composition |
| 04/13/2010 | CA2257357C Humanized antibodies with modified glycosylation |
| 04/13/2010 | CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/13/2010 | CA2153593C Compositions and methods for delivery of genetic material |
| 04/13/2010 | CA2089229C Cd40cr receptor and ligands therefor |
| 04/08/2010 | WO2010040051A2 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells |
| 04/08/2010 | WO2010039861A2 Dendrimer conjugates |
| 04/08/2010 | WO2010039762A2 Pharmaceutical compositions comprising boronic acid compounds |
| 04/08/2010 | WO2010039496A2 Nanocarriers for drug delivery |
| 04/08/2010 | WO2010039163A2 Chemical and biochemical adducts as biomarkers for organophosphate exposure |
| 04/08/2010 | WO2010039088A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 04/08/2010 | WO2010039039A1 Oral formulations of gemcitabine derivatives |
| 04/08/2010 | WO2010039006A2 Method of manufacturing solid microstructure and solid microstructure manufactured based on same |
| 04/08/2010 | WO2010038771A1 Light-stabilized pharmaceutical composition |
| 04/08/2010 | WO2010038756A1 PHARMACEUTICAL COMPOSITION FOR TREATING BONE DISEASES WHICH COMPRISES PROTEIN COMPRISING Frizzled1, Frizzled2 OR Frizzled7 EXTRACELLULAR CYSTEINE-RICH DOMAIN |
| 04/08/2010 | WO2010038747A1 Hydrophilic material, medical material and sustained release pharmaceutical material |
| 04/08/2010 | WO2010038695A1 Compression-molded preparation and method for producing the same |
| 04/08/2010 | WO2010038691A1 Particulate pharmaceutical composition for oral administration |
| 04/08/2010 | WO2010038690A1 Controlled release pharmaceutical composition |
| 04/08/2010 | WO2010038689A1 Pharmaceutical composition for oral administration |
| 04/08/2010 | WO2010038688A1 Particulate pharmaceutical composition for oral administration of atorvastatin |
| 04/08/2010 | WO2010038241A2 Pharmaceutical compositions comprising of proton pump inhibitor, prokinetic agent and alginic acid |
| 04/08/2010 | WO2010038129A1 Mucomimetic compositions and uses therefore |
| 04/08/2010 | WO2010038010A1 Somatostatin analogues |
| 04/08/2010 | WO2010037878A1 Utilisation of nanoparticles of noble metals as immunomodulators and immunomodulator composition |
| 04/08/2010 | WO2010037856A2 DYNACTIN-1/p150glued AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY AND A METHOD FOR IDENTIFYING TARGETABLE DISEASE-RELATED PROTEINS |
| 04/08/2010 | WO2010037854A2 Alcohol-resistant tablet |
| 04/08/2010 | WO2010037753A1 New controlled release active agent carrier |
| 04/08/2010 | WO2010037539A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 04/08/2010 | WO2010037408A1 Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| 04/08/2010 | WO2010037402A1 Molecular vaccines for infectious disease |
| 04/08/2010 | WO2010037398A1 Oral formulation |
| 04/08/2010 | WO2010037397A1 Mhc multimers in cmv immune monitoring |
| 04/08/2010 | WO2010037395A2 Mhc multimers in cancer vaccines and immune monitoring |
| 04/08/2010 | WO2010037352A1 Pharmaceutical composition utilising combinations of variants of the gonadotropin-liberating hormone (gnrh) as immunogen |
| 04/08/2010 | WO2010037284A1 Polypeptides for treating or preventing cancers, the derivative products and uses thereof |
| 04/08/2010 | WO2010019890A3 Vaccine for shigella |
| 04/08/2010 | WO2010004433A3 Hydrophobically enhanced aminoglycosides |
| 04/08/2010 | WO2010003465A3 A drug powder for inhalation administration and a process thereof |
| 04/08/2010 | WO2009156675A3 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid |
| 04/08/2010 | WO2009155397A3 Edible holographic silk products |
| 04/08/2010 | WO2009129509A4 Methods and compositions for treating post-operative pain comprising a local anesthetic |
| 04/08/2010 | WO2009129453A4 Clonidine formulation in a polyorthoester carrier |
| 04/08/2010 | WO2009129437A4 Methods and compositions for treating post-operative pain comprising clonidine |
| 04/08/2010 | US20100087550 Formulations with a Tertiary Amine Oxide |
| 04/08/2010 | US20100087549 Extended release excipient and its use |
| 04/08/2010 | US20100087507 Use of rpn2 gene expression inhibitor |
| 04/08/2010 | US20100087501 Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex |
| 04/08/2010 | US20100086972 Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports |
| 04/08/2010 | US20100086624 Colon cleansing compositions and methods |
| 04/08/2010 | US20100086612 Coated carriers |
| 04/08/2010 | US20100086610 Vault and vault-like carrier molecules |
| 04/08/2010 | US20100086609 Methods and Compositions for Delivering Peptides |
| 04/08/2010 | US20100086607 Self-Assembled Biodegradable Nanoparticles for Medical and Biological Applications |
| 04/08/2010 | US20100086594 Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
| 04/08/2010 | US20100086559 Polypeptide formulation |
| 04/08/2010 | CA2778604A1 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same |
| 04/08/2010 | CA2740342A1 Pharmaceutical composition for modified release |
| 04/08/2010 | CA2739018A1 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules |